NuFACTOR Introduces Online Immune Globulin Therapy Tracking System for Homecare Patients.TEMECULA, Calif. -- NuFACTOR, a specialty pharmacy services company, went live today with its Immune Globulin Immune globulin Serum containing antibodies against a specific infection. Mentioned in: Maternal to Fetal Infections Treatment Tracker (IGTT IGTT Impaired Glucose Tolerance Test ), an online system for homecare patients to independently track, monitor and report their immune globulin therapy. NuFACTOR is a division of the Temecula-headquartered healthcare corporation FFF (FreeForm Fabrication) See rapid manufacturing and 3D printing. Enterprises, the nation's largest distributor of immune globulin products, vaccines and other biopharmaceuticals. NuFACTOR provides services to patients with chronic diseases who are treated with infusion therapies in their homes. Immune globulin, made from human plasma, is used to treat many conditions, including primary immune deficiency immune deficiency n. See immunodeficiency. diseases, neuropathies, myositis myositis Inflammation of muscle tissue, often from bacterial, viral, or parasitic infection but sometimes of unknown origin. Most types destroy muscle and surrounding tissue. Bacteria may directly infect muscle (usually after injury) or produce substances toxic to it. , Guillain-Barre syndrome Guil·lain-Bar·ré syndrome n. See acute idiopathic polyneuritis. and others. IGTT represents a new, collaborative approach for healthcare consumers who are increasingly requesting a more active role in managing their treatment plans in cooperation with their healthcare providers. "IG Treatment Tracker is the first Web-based system in the nation that puts consumers in control of their home immune globulin therapy," said Patrick M. Schmidt, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of NuFACTOR and FFF Enterprises. "The system improves communication between patients and their healthcare providers by providing a comprehensive view of the patient's treatment and related health issues between office visits. The increased flow of information helps patients and their physicians more effectively manage treatment and compliance." IG Treatment Tracker allows patients who regularly infuse in·fuse v. 1. To steep or soak without boiling in order to extract soluble elements or active principles. 2. To introduce a solution into the body through a vein for therapeutic purposes. immune globulin to maintain complete infusion and health logs, including product lot numbers, infusion method, amounts and rates, exact administration sites on a body image, infusion attempts and reactions, and other medical information. Patients can retrieve their securely stored information at their discretion to share with physicians and other healthcare providers. IG Treatment Tracker stores all patient information in a private, HIPAA-compliant record that patients can access and update at any time. No additional program downloading is necessary, and the only technical requirement is Internet access See how to access the Internet. . "We are pleased to be able to provide IG Treatment Tracker as a complimentary service to NuFACTOR patients," Schmidt said. "The freedom and control the system offers to help healthcare consumers is empowering." For more information about IG Treatment Tracker, visit www.nufactor.com or call NuFACTOR at 800-323-6832. About NuFACTOR FFF Enterprises, the nation's largest immune globulin distributor, established NuFACTOR, its specialty pharmacy services division, in 1995. NuFACTOR was founded on the principles of responsibly listening and respectfully responding to healthcare consumers. NuFACTOR is dedicated to solving the chronic problems of affordability, availability and safety in disease state management for chronically ill patients. The company is deeply committed to the philosophy of providing philanthropic support to the patient communities it serves. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion